2nd Quarter - Report

EMD MILLIPORE CORPORATION for EMD MILLIPORE CORPORATION

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to emerging technologies in drug manufacturing

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Food & Drug Administration (FDA)

Manufacturing MAN

Discussions regarding appropriations related to biomanufacturing and Industrial Base Expansion Discussions related to deuterated water production

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Energy, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Trade (domestic/foreign) TRD

Discussions related to the inclusion of biotechnology in prospective Executive Order to require federal screening of outbound investments

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Commerce, Dept of (DOC)

Food Industry (safety, labeling, etc.) FOO

Discussions related to cultured meat

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.